Targeting TLR4 with ligustrazine and AT1R with telmisartan ameliorates diabetic kidney disease

Translational Research · Published 2026-08-01 · DOI 10.1016/j.trsl.2026.08.001

Authors (2)

Pratik Shankar Rakshe, Anil Bhanudas Gaikwad

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rakshe, P., Gaikwad, A. (2026). Targeting TLR4 with ligustrazine and AT1R with telmisartan ameliorates diabetic kidney disease. Translational Research. https://doi.org/10.1016/j.trsl.2026.08.001

Related articles

• Editorial Advisory Board · Translational Research · 2026 · Same journal
• Single cell RNA-sequencing meta-analysis identifies the molecular signature of smoking cessation on the human lung · Translational Research · 2026 · Same journal
• A self-sustaining repair circuit drives the progression of pulmonary fibrosis · Translational Research · 2026 · Same journal
• Editorial Advisory Board · Translational Research · 2026 · Same journal
• Author Guidelines · Translational Research · 2026 · Same journal
• From JAK2 degradation to precision immunotherapy: A translational passport for strebloside in Epstein–Barr virus-associated gastric cancer · Translational Research · 2026 · Same journal
• Editorial Advisory Board · Translational Research · 2026 · Same journal
• Ion channel dysfunction in acute pancreatitis: mechanisms, heterogeneity, and therapeutic prospects · Translational Research · 2026 · Same journal
• Autologous airway basal cell transplantation for destroyed lung repair · Translational Research · 2026 · Same journal
• Circ-PHC3 promotes malignant progression of ovarian cancer through regulating miR-512-3p/SLC2A1/HK2 mediated glucose metabolism · Translational Research · 2026 · Same journal